Eligibility Criteria

Inclusion Criteria:

- Male and females, between the ages of 21 and 50;

- No current dependence or abuse of drugs of abuse or alcohol (except and tobacco);

- No current medical problems and normal ECG;

- For women, not pregnant as determined by pregnancy screening nor breast feeding, and
using acceptable birth control methods.

Exclusion Criteria:

- Current major psychiatric illnesses including mood, psychotic, or anxiety disorders;

- History of major medical illnesses; including liver diseases, heart disease, or other
medical conditions that the physician investigator deems contraindicated for the
subject to be in the study;

- Known allergy to Atomoxetine;

- Use of Monoamine Oxidase inhibitor within the last month (clinically Atomoxetine
administration is contraindicated with or within 2 weeks of discontinuation of
Monoamine oxidase inhibitor therapy).